Ignite Creation Date:
2024-05-06 @ 12:48 PM
Last Modification Date:
2024-10-26 @ 1:04 PM
Study NCT ID:
NCT03854903
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-21
First Post:
2019-02-21
Brief Title:
WI231696 Bosutinib Palbocicilib and Fulvestrant for HRHER2- Advanced Breast Cancer Refractory to a CDK46 Inhibitor
Sponsor:
Georgetown University
Organization:
Georgetown University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Breast Cancer |
| Human Epidermal Growth Factor 2 Negative Carcinoma of Breast |
| Hormone Receptor Positive Breast Cancer |